1.1Gel at the wound margin
A viscous gel containing gelatin and sodium carboxymethylcellulose is dispensed onto intact skin around the wound. The ring fills gaps beneath the cover film, and a separate absorbent pad takes up fluid from the wound bed.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
A viscous gel containing gelatin and sodium carboxymethylcellulose is dispensed onto intact skin around the wound. The ring fills gaps beneath the cover film, and a separate absorbent pad takes up fluid from the wound bed.
An open-cell polyurethane foam has a thin, crosslinked collagen coating on its wound-facing surface. Interconnected pores draw in exudate by capillary action and hold it within the foam.
A hydrated polyvinyl alcohol sheet contains sodium hyaluronate dispersed in its aqueous phase. The sheet conforms to the wound surface, and the hyaluronate binds water at the interface.
Water-soluble collagen peptides are dispersed in a hydrated polyvinyl alcohol gel. Dissolved peptides diffuse through the gel's water phase into fluid at the wound surface.
A dry calcium alginate nonwoven carries a crosslinked collagen coating on its wound-facing fibers. Sodium ions in exudate exchange with calcium ions in the alginate, and the hydrated fibers form a soft gel.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
A sterile transport cassette holds a pre-gelled agarose pad with type I collagen covalently attached to its contact face. An excised skin graft rests dermal side down on the pad, which is hydrated with isotonic buffer before loading. A peripheral frame holds the pad in place while the sealed cassette limits moisture loss during transfer between preparation and placement.
A crosslinked polyethylene glycol hydrogel forms the wound contact sheet. A fraction of the gelatin amino groups carries thiol groups, which react with vinyl sulfone groups on the polyethylene glycol and tether the gelatin during gelation. The cured sheet is washed with isotonic saline to remove soluble residues and is placed over the wound in its hydrated state.
A crosslinked dextran hydrogel carries a short collagen-derived peptide in place of a full-length protein. A terminal cysteine on the peptide reacts with a fraction of the maleimide groups on modified dextran, and a bifunctional thiol consumes the remaining groups to form the gel network. The sheet is equilibrated in isotonic saline before placement over the wound, and the covalent tether retains the peptide in the hydrated network.
A pre-gelled sheet of calcium alginate containing covalently tethered gelatin is cast at 2 mm thickness and cut into 10 mm squares. The squares are placed in a staggered pattern with gaps of 0.5 to 1 mm between neighboring edges. Each square follows the local surface contour, and the gaps accommodate bending between squares.
A pre-gelled polyethylene glycol contact sheet carries covalently tethered gelatin and has through-holes across its wound-facing area. A porous foam manifold sits above the sheet inside a sealed negative pressure dressing. A suction line connects the foam to a collection canister, and wound fluid passes through the holes into the foam and onward to the canister.
A camera captures the wound and a disposable scale marker positioned beside it in the same plane. Software converts a clinician-traced wound outline to millimeter coordinates and sends the contour to an enclosed knife cutter fitted with a sterile blade and tray. The cutter trims a pre-gelled sheet bearing covalently immobilized gelatin, and the clinician places the trimmed sheet over the wound.
A hydrated polyvinyl alcohol sheet carries a crosslinked collagen coating on its wound-facing side. The sheet is laid across the wound bed and held in place by a secondary cover.
A hydrated calcium alginate sheet contains crosslinked gelatin particles distributed through its wound-facing layer. The sheet conforms to the wound surface and takes up exudate as the alginate swells.
Carboxyl groups on a hydrated alginate sheet are activated and coupled to amino groups on collagen peptides to form amide bonds. The sheet is then washed to remove unbound peptide and stored hydrated in a sealed pouch.
Gelatin and a multi-arm polyethylene glycol crosslinker with activated ester end groups are mixed in aqueous buffer and cast into a sheet. Amide bonds anchor the gelatin throughout the network, and the hydrated sheet is packaged after the gel sets.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
The present applicator comprises a rigid body (20) having a rigid body enclosure (30) for receiving a wound dressing, and an ejector (40) for ejecting the wound dressing from the rigid body enclosure and onto a patient's wound.A · US 2011/0118645 A1 · abstract
The invention described here relates to a method for the incorporation of the above nano- or microspheres into electrospun fibers consisting of PLA under formation of 3D mats suitable as antimicrobial and regenerative dressings for wound healing.B · US 2017/0319740 A1 · ¶ 31
An empty cell means only that no passage was reproduced there.
A problem associated with this type of known wound dressing application system is that the means for applying the wound dressing to the patient's skin is flexible, which means that it can be difficult to handle the dressing and to accurately position it to cover a wound.A · US 2011/0118645 A1 · ¶ 3
Also, the use of flexible packaging sheets does not adequately protect the wound dressing from damage during transit and general handling of the wound dressing delivery systems.A · US 2011/0118645 A1 · ¶ 3
A further aspect of this invention concerns the incorporation of such nano- or microparticles, after encapsulation of retinol (“retinol/aCa-polyP nano- or microspheres”), into wound dressings and related materials that are made, e.g., by electrospinning.B · US 2017/0319740 A1 · ¶ 1
The resulting, inventive retinol/aCa-polyP nano- or microspheres fiber mats show antimicrobial and wound healing properties and was found to increase the expression of the genes encoding for leptin and the leptin receptor, as well as the fatty acid binding protein 4 (FABP4) in a synergistic manner.B · US 2017/0319740 A1 · ¶ 1
patent.fyi, US 2026/0355381 A1, claim 1, first published 2026-11-19T10:59:45-05:00, https://patent.fyi/US20260355381/, SHA-256 adb120ead5538c4215c86c27fee4a314f79804566366a1ff63a70f0ba4dea7ad